The KY protein has been implicated in a neuromuscular dystrophy in the mouse, but its role in muscle function remains unclear. Here, we show that KY interacts with several sarcomeric cytoskeletal proteins including, amongst others, filamin C and the slow isoform of the myosin-binding protein C. These interactions were confirmed in vitro and because of its central role in skeletal muscle disease, characterized in more detail for filamin C. A role for KY in regulating filamin C function in vivo is supported by the expression analysis of filamin C in the null ky mouse mutant, where distinct irregular subcellular localization of filamin C was found in subsets of muscle fibres, which appears to be a specific outcome of KY deficiency. Furthermore, KY shows protease activity in in vitro assays, and specific degradation of filamin C by KY is shown in transfected cells. Given the enzymatic nature of the KY protein, it is likely that some of the identified partners are catalytic substrates. These results suggest that KY is an intrinsic part of the protein networks underlying the molecular mechanism of several limb-girdle muscular dystrophies, particularly those where interactions between filamin C and disease causing proteins have been shown.

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddh308DOI Listing

Publication Analysis

Top Keywords

filamin
8
muscle fibres
8
protein
5
filamin interacts
4
interacts muscular
4
muscular dystrophy
4
dystrophy protein
4
protein abnormally
4
abnormally distributed
4
distributed mouse
4

Similar Publications

Filamin C (FLNC), recently identified as a causative gene of cardiomyopathy, is widely expressed in cardiomyocytes and is involved in signal transduction between the sarcomere and the plasma membrane. In general, the FLNC truncating variant causes severe dilated cardiomyopathy. A 70-year-old female was referred to our hospital with advanced conduction defects and underwent pacemaker implantation.

View Article and Find Full Text PDF

Periventricular nodular heterotopia (PVNH) is a neuronal migration disorder often associated with drug-resistant epilepsy. The epileptogenic zone network (EZN) in PVNH is generally large, contraindicating surgery. Stereoelectroencephalography (SEEG) can be proposed to map the EZN and perform radiofrequency thermocoagulation (THC) with an efficacy rate of approximately 65%.

View Article and Find Full Text PDF

and mutation-related spondylocarpotarsal synostosis: a case report.

J Yeungnam Med Sci

December 2024

Department of Physical Medicine and Rehabilitation, Sahmyook Medical Center, Seoul, Korea.

Spondylocarpotarsal synostosis syndrome (SCTS) is a rare genetic disorder characterized by vertebral fusion, short stature, and skeletal anomalies. SCTS is primarily associated with mutations in filamin B. However, in this report, we present a unique case of SCTS in a 28-year-old male who complained of neck and shoulder pain persisting for 1 year.

View Article and Find Full Text PDF

Augmenting the portfolio of therapeutics for type 2-driven diseases is crucial to address unmet clinical needs and to design personalized treatment schemes. An attractive therapy for such diseases would consist in targeting the recruitment of T helper 2 (Th2) lymphocytes to inflammatory sites. Herein, we show the degradation of filamins (FLN) a and b by the ASB2α E3 ubiquitin ligase as a mechanism sustaining Th2 lymphocyte functions.

View Article and Find Full Text PDF

S6K/FLNC/ITGβ3 signaling pathway regulates osteoclastogenesis and the inhibition of osteoclastogenesis by columbianadin.

Phytomedicine

November 2024

Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China; State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, West Area, Tuanbo New Town, Jinghai District, Tianjin 301617, PR China. Electronic address:

Article Synopsis
  • - The study investigates the effects of Columbianadin (CBN), a compound from traditional medicine, on inhibiting osteoclastogenesis, which contributes to bone loss, and seeks to identify its underlying mechanisms.
  • - Researchers used transcriptomics, RT-PCR, Western blot analysis, and proteomics to uncover changes in gene expression during osteoclast differentiation, focusing on the S6K/FLNC/ITGβ3 signaling pathway.
  • - Results showed that CBN significantly reduced FLNC levels, which in turn decreased markers of osteoclast differentiation and bone resorption in ovariectomized mice, suggesting CBN could be a therapeutic option for bone-related disorders.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!